Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Thiocolchicine [2730-71-4]
Cat# T41248-50mg
Size : 50mg
Brand : TargetMol
Thiocolchicine
Catalog No. T41248 CAS 2730-71-4
Thiocolchicine is an effective inhibitor of tubulin polymerization with an IC50 of 2.5 µM and a Ki of 0.7 µM. Thiocolchicine induces cell apoptosis. Thiocolchicine can be used as an ADC cytotoxin in ADC technology.
All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
Thiocolchicine, CAS 2730-71-4
Description | Thiocolchicine is an effective inhibitor of tubulin polymerization with an IC50 of 2.5 µM and a Ki of 0.7 µM. Thiocolchicine induces cell apoptosis. Thiocolchicine can be used as an ADC cytotoxin in ADC technology. |
Targets&IC50 | Tubulin polymerization:0.7 µM(Ki), Tubulin polymerization:2.5 µM |
In vitro | Thiocolchicine (1 nM-100 μM; 24-72 hours) shows a relationship between cell cycle blocking activity and growth inhibition in breast cancer cells. Thiocolchicine inhibits cell proliferation of MDA-MB-231 and multidrug-resistant (MDR) MCF-7 ADRr breast cancer cells with IC50s of 0.6 nM and 400 nM, respectively, as well as MDR CEM-VBL leukemia cells with an IC50 of 50 nM[1]. Thiocolchicine is against MCF-7, LoVo, LoVo/DX, A-549 and BALB/3T3 cells with IC50 values of 0.01 μM, 0.021 μM, 0.398 μM, 0.011 μM and 0.114 μM, respectively[2]. |
Molecular Weight | 415.5 |
Formula | C22H25NO5S |
CAS No. | 2730-71-4 |
Storage
Solubility Information
DMSO: 95 mg/mL (228.64 mM), Sonication is recommended.
References and Literature
1. R De Vincenzo, et al. Antiproliferative Activity of Colchicine Analogues on MDR-positive and MDR-negative Human Cancer Cell Lines. Anticancer Drug Des. 1998 Jan;13(1):19-33. 2. Klaus M.Hahn, et al. Structural requirements for the binding of colchicine analogs to tubulin: the role of the C-10 substituent. Bioorganic & Medicinal Chemistry Letters.Volume 1, Issue 9, 1991, Pages 471-476